| Kerry Lynn Blum, | |
|
3531 S Logan, D347, Englewood, CO 80110-3700 | |
| (303) 321-9700 | |
| (303) 953-9211 |
| Full Name | Kerry Lynn Blum |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 25 Years |
| Location | 3531 S Logan, Englewood, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982787974 | NPI | - | NPPES |
| P00632046 | Other | CO | RAIL ROAD MEDICARE |
| 46580719 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 39003 (Colorado) | Primary |
| 207Q00000X | Family Medicine | 39003 (Colorado) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Centura Health-porter Adventist Hospital | Denver, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Portercare Adventist Health System | 0941110886 | 547 |
News Archive
The U.S. Food and Drug Administration today approved a remote feature for follow-up programming sessions for the Nucleus Cochlear Implant System through a telemedicine platform.
Leaders of the Texas Plant-Expressed Vaccine Consortium today announced a biotherapeutic manufacturing initiative designed to show proof of concept for a landmark new technology that could dramatically increase the nation's capability to produce vaccines for infectious diseases, including influenza.
Led by the Basque R&D Alliance IK4, 13 organisations in 8 different countries have been conducting research for three years under the European LabOnFoil project to develop new rapid diagnostic devices.
Acclarent, Inc. announced today the U.S. availability of the Relieva Spin Balloon Sinuplasty System with the M-110C Sinus Guide Catheter Tip designed to access small and tight sinus anatomy in children and adults. This innovation represents a new addition to Acclarent's Balloon Sinuplasty portfolio, which physicians use to treat children who suffer from chronic maxillary sinusitis.
Victims of bullying in secondary school have dramatically increased chances of mental health problems and unemployment in later life.
› Verified 5 days ago
| Entity Name | Catholic Health Initiatives Colorado |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356783351 PECOS PAC ID: 8022927342 Enrollment ID: O20031215000462 |
News Archive
The U.S. Food and Drug Administration today approved a remote feature for follow-up programming sessions for the Nucleus Cochlear Implant System through a telemedicine platform.
Leaders of the Texas Plant-Expressed Vaccine Consortium today announced a biotherapeutic manufacturing initiative designed to show proof of concept for a landmark new technology that could dramatically increase the nation's capability to produce vaccines for infectious diseases, including influenza.
Led by the Basque R&D Alliance IK4, 13 organisations in 8 different countries have been conducting research for three years under the European LabOnFoil project to develop new rapid diagnostic devices.
Acclarent, Inc. announced today the U.S. availability of the Relieva Spin Balloon Sinuplasty System with the M-110C Sinus Guide Catheter Tip designed to access small and tight sinus anatomy in children and adults. This innovation represents a new addition to Acclarent's Balloon Sinuplasty portfolio, which physicians use to treat children who suffer from chronic maxillary sinusitis.
Victims of bullying in secondary school have dramatically increased chances of mental health problems and unemployment in later life.
› Verified 5 days ago
| Entity Name | Carepoint Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275516346 PECOS PAC ID: 0547154957 Enrollment ID: O20040209000313 |
News Archive
The U.S. Food and Drug Administration today approved a remote feature for follow-up programming sessions for the Nucleus Cochlear Implant System through a telemedicine platform.
Leaders of the Texas Plant-Expressed Vaccine Consortium today announced a biotherapeutic manufacturing initiative designed to show proof of concept for a landmark new technology that could dramatically increase the nation's capability to produce vaccines for infectious diseases, including influenza.
Led by the Basque R&D Alliance IK4, 13 organisations in 8 different countries have been conducting research for three years under the European LabOnFoil project to develop new rapid diagnostic devices.
Acclarent, Inc. announced today the U.S. availability of the Relieva Spin Balloon Sinuplasty System with the M-110C Sinus Guide Catheter Tip designed to access small and tight sinus anatomy in children and adults. This innovation represents a new addition to Acclarent's Balloon Sinuplasty portfolio, which physicians use to treat children who suffer from chronic maxillary sinusitis.
Victims of bullying in secondary school have dramatically increased chances of mental health problems and unemployment in later life.
› Verified 5 days ago
| Entity Name | Portercare Adventist Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760761928 PECOS PAC ID: 0941110886 Enrollment ID: O20090115000327 |
News Archive
The U.S. Food and Drug Administration today approved a remote feature for follow-up programming sessions for the Nucleus Cochlear Implant System through a telemedicine platform.
Leaders of the Texas Plant-Expressed Vaccine Consortium today announced a biotherapeutic manufacturing initiative designed to show proof of concept for a landmark new technology that could dramatically increase the nation's capability to produce vaccines for infectious diseases, including influenza.
Led by the Basque R&D Alliance IK4, 13 organisations in 8 different countries have been conducting research for three years under the European LabOnFoil project to develop new rapid diagnostic devices.
Acclarent, Inc. announced today the U.S. availability of the Relieva Spin Balloon Sinuplasty System with the M-110C Sinus Guide Catheter Tip designed to access small and tight sinus anatomy in children and adults. This innovation represents a new addition to Acclarent's Balloon Sinuplasty portfolio, which physicians use to treat children who suffer from chronic maxillary sinusitis.
Victims of bullying in secondary school have dramatically increased chances of mental health problems and unemployment in later life.
› Verified 5 days ago
| Entity Name | Colorado Hospitalist Services, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265806178 PECOS PAC ID: 4486957578 Enrollment ID: O20160123000040 |
News Archive
The U.S. Food and Drug Administration today approved a remote feature for follow-up programming sessions for the Nucleus Cochlear Implant System through a telemedicine platform.
Leaders of the Texas Plant-Expressed Vaccine Consortium today announced a biotherapeutic manufacturing initiative designed to show proof of concept for a landmark new technology that could dramatically increase the nation's capability to produce vaccines for infectious diseases, including influenza.
Led by the Basque R&D Alliance IK4, 13 organisations in 8 different countries have been conducting research for three years under the European LabOnFoil project to develop new rapid diagnostic devices.
Acclarent, Inc. announced today the U.S. availability of the Relieva Spin Balloon Sinuplasty System with the M-110C Sinus Guide Catheter Tip designed to access small and tight sinus anatomy in children and adults. This innovation represents a new addition to Acclarent's Balloon Sinuplasty portfolio, which physicians use to treat children who suffer from chronic maxillary sinusitis.
Victims of bullying in secondary school have dramatically increased chances of mental health problems and unemployment in later life.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kerry Lynn Blum, 2525 S Downing St, D347, Denver, CO 80210-5817 Ph: (303) 765-6891 | Kerry Lynn Blum, 3531 S Logan, D347, Englewood, CO 80110-3700 Ph: (303) 321-9700 |
News Archive
The U.S. Food and Drug Administration today approved a remote feature for follow-up programming sessions for the Nucleus Cochlear Implant System through a telemedicine platform.
Leaders of the Texas Plant-Expressed Vaccine Consortium today announced a biotherapeutic manufacturing initiative designed to show proof of concept for a landmark new technology that could dramatically increase the nation's capability to produce vaccines for infectious diseases, including influenza.
Led by the Basque R&D Alliance IK4, 13 organisations in 8 different countries have been conducting research for three years under the European LabOnFoil project to develop new rapid diagnostic devices.
Acclarent, Inc. announced today the U.S. availability of the Relieva Spin Balloon Sinuplasty System with the M-110C Sinus Guide Catheter Tip designed to access small and tight sinus anatomy in children and adults. This innovation represents a new addition to Acclarent's Balloon Sinuplasty portfolio, which physicians use to treat children who suffer from chronic maxillary sinusitis.
Victims of bullying in secondary school have dramatically increased chances of mental health problems and unemployment in later life.
› Verified 5 days ago
Dr. Gary Michael Breen, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 501 E Hampden Ave, Englewood, CO 80113 Phone: 303-338-4545 | |
Oxana V. Norvell, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 501 E Hampden Ave, Englewood, CO 80113 Phone: 303-788-6911 Fax: 303-306-7753 | |
Jack R Smardo, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 499 East Hampden, #320, Englewood, CO 80113 Phone: 303-781-8439 Fax: 303-788-6115 | |
Charles E. Koftan, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 799 E Hampden Ave, 300, Englewood, CO 80113 Phone: 303-493-5200 Fax: 720-570-2012 | |
Dr. Swathi Nemani, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 501 E Hampden Ave, Englewood, CO 80113 Phone: 720-940-5810 | |
Edward W Carriere Jr., MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 499 East Hampden, #320, Englewood, CO 80113 Phone: 303-781-8439 Fax: 303-788-6115 | |
Blake R Parsons, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 501 E Hampden Ave, Englewood, CO 80113 Phone: 303-338-4545 |